ADAMTS13
Basic information
Region (hg38): 9:133414358-133459402
Previous symbols: [ "C9orf8" ]
Links
Phenotypes
GenCC
Source:
- congenital thrombotic thrombocytopenic purpura (Strong), mode of inheritance: AR
- congenital thrombotic thrombocytopenic purpura (Strong), mode of inheritance: AR
- congenital thrombotic thrombocytopenic purpura (Supportive), mode of inheritance: AR
- congenital thrombotic thrombocytopenic purpura (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thrombotic thrombocytopenic purpura, hereditary (Schulman-Upshaw syndrome) | AR | Hematologic; Obstetric | Medical management (eg, with administration of plasma; trials of recombinant ADAMTS13 have also had promising results) can be beneficial; Specific treatment in pregnancy may be indicated | Hematologic; Neurologic; Renal | 14443744; 651994; 7290149; 11530798; 11586351; 12181489; 12576319; 12637323; 19055667; 38692292 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (633 variants)
- Upshaw-Schulman_syndrome (401 variants)
- Inborn_genetic_diseases (143 variants)
- not_specified (74 variants)
- ADAMTS13-related_disorder (49 variants)
- Thrombotic_thrombocytopenic_purpura (9 variants)
- Atypical_hemolytic-uremic_syndrome (3 variants)
- Thrombus (3 variants)
- See_cases (3 variants)
- Thrombocytopenia (2 variants)
- Abnormal_bleeding (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS13 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000139027.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 162 | 193 | |||
missense | 12 | 30 | 395 | 44 | 484 | |
nonsense | 14 | 23 | ||||
start loss | 0 | |||||
frameshift | 24 | 37 | ||||
splice donor/acceptor (+/-2bp) | 15 | 19 | ||||
Total | 52 | 62 | 425 | 207 | 10 |
Highest pathogenic variant AF is 0.0010946
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAMTS13 | protein_coding | protein_coding | ENST00000371929 | 29 | 45031 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.14e-15 | 1.00 | 125676 | 0 | 72 | 125748 | 0.000286 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.56 | 734 | 863 | 0.850 | 0.0000582 | 9105 |
Missense in Polyphen | 176 | 235.34 | 0.74786 | 2683 | ||
Synonymous | 0.864 | 337 | 358 | 0.942 | 0.0000241 | 2976 |
Loss of Function | 3.70 | 35 | 67.9 | 0.515 | 0.00000333 | 740 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000796 | 0.000779 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000560 | 0.000544 |
Finnish | 0.0000930 | 0.0000924 |
European (Non-Finnish) | 0.000233 | 0.000229 |
Middle Eastern | 0.000560 | 0.000544 |
South Asian | 0.000305 | 0.000294 |
Other | 0.000528 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves the vWF multimers in plasma into smaller forms thereby controlling vWF-mediated platelet thrombus formation. {ECO:0000269|PubMed:19880749}.;
- Disease
- DISEASE: Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150]: A hematologic disease characterized by hemolytic anemia with fragmentation of erythrocytes, thrombocytopenia, diffuse and non-focal neurologic findings, decreased renal function and fever. recessive. {ECO:0000269|PubMed:11586351, ECO:0000269|PubMed:12181489, ECO:0000269|PubMed:12393505, ECO:0000269|PubMed:12614216, ECO:0000269|PubMed:12753286, ECO:0000269|PubMed:14512317, ECO:0000269|PubMed:14563640, ECO:0000269|PubMed:15009458, ECO:0000269|PubMed:15126318, ECO:0000269|PubMed:15327386, ECO:0000269|PubMed:16160007, ECO:0000269|PubMed:16449289, ECO:0000269|PubMed:16453338, ECO:0000269|PubMed:16796708, ECO:0000269|PubMed:16807643, ECO:0000269|PubMed:17003922, ECO:0000269|PubMed:18443791, ECO:0000269|PubMed:19055667, ECO:0000269|PubMed:19116307, ECO:0000269|PubMed:22075512}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.523
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.42
Haploinsufficiency Scores
- pHI
- 0.0682
- hipred
- N
- hipred_score
- 0.332
- ghis
- 0.542
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.150
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adamts13
- Phenotype
- homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; pigmentation phenotype; immune system phenotype;
Gene ontology
- Biological process
- proteolysis;cell-matrix adhesion;integrin-mediated signaling pathway;glycoprotein metabolic process;response to toxic substance;response to amine;protein processing;platelet activation;response to potassium ion;peptide catabolic process;cellular response to lipopolysaccharide;cellular response to interferon-gamma;cellular response to interleukin-4;cellular response to tumor necrosis factor
- Cellular component
- extracellular space;endoplasmic reticulum lumen;cell surface;extracellular matrix
- Molecular function
- metalloendopeptidase activity;integrin binding;calcium ion binding;protein binding;metallopeptidase activity;zinc ion binding